Glenmark gets ANDA approval for Calcipotriene and Betamethasone Dipropionate Foam, 0.005%|0.064%
With this approval, Glenmark is eligible for 180-days of generic drug exclusivity for Calcipotriene and Betamethasone Dipropionate…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Drug approvals
Glenmark gets USFDA approval for Prochlorperazine Maleate Tablets USP, 5 mg and 10 mg
Glenmarkâs current portfolio consists of 182 products authorised for distribution in the US marketplace
Unichem gets USFDA approval for ranolazine ER tablets, 500 mg and 1000 mg
Ranolazine ER tablets are indicated for the treatment of chronic angina
Eli Lilly launches Copellor in India to treat moderate-to-severe plaque psoriasis
A humanised IgG4 monoclonal antibody, Copellor (Ixekizumab) is designed to specifically target IL-17A, a protein that plays a role…
Glenmark gets ANDA approval for Clindamycin Hydrochloride Capsules
Glenmark Pharmaceuticals has received final approval from the United States Food & Drug Administration (US FDA) for…
USFDA accepts Eisai’s sBLA and grants priority review for approval of LEQEMBITM…
USFDA accepts Eisai's sBLA and grants priority review for approval of LEQEMBITM Alzheimer's treatment
Alembic Pharma gets USFDA nod for Fluorouracil Injection USP, 2.5 g/50 mL pharmacy bulk vial
It is indicated for the treatment of patients with adenocarcinoma of colon and rectum, adenocarcinoma of the breast, gastric…
Zydus gets final US FDA approval for Vigabatrin for Oral Solution USP, 500 mg
Vigabatrin for oral solution is indicated for the treatment of refractory complex partial seizures as adjunctive therapy in…
Caplin Steriles gets USFDA approval for Rocuronium Bromide Injection
Rocuronium Bromide Injection is a neuromuscular blocking agent, indicated as an adjunct to general anesthesia to facilitate both…
Zydus gets tentative nod from USFDA for Gabapentin Tablets, 300 mg and 600 mg
Gabapentin tablets are indicated for the management of Postherpetic Neuralgia (PHN)